Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys (Q42552539)

2 November 2017

Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys (English)

1 reference

2 November 2017

0 references

1 reference

1 reference

5

Agid Y

1 reference

PubMed ID

8915594

2 November 2017

Maria Trinidad Herrero

series ordinal

1

object named as

María Trinidad Herrero

1 reference

2 November 2017

2

Sarah J. Augood

1 reference

2 November 2017

3

Hélène Asensi

1 reference

2 November 2017

4

Etienne C. Hirsch

1 reference

2 November 2017

6

Jose A. Obeso

1 reference

PubMed ID

8915594

2 November 2017

Piers Christopher Emson

series ordinal

7

object named as

Piers Christopher Emson

1 reference

2 November 2017

1 November 1996

1 reference

2 November 2017

Molecular Brain Research

1 reference

2 November 2017

42

1 reference

2 November 2017

1

1 reference

2 November 2017

149-155

1 reference

The functional anatomy of basal ganglia disorders

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Neuronal types in the striatum of man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Striatal interneurones: chemical, physiological and morphological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Dopamine receptor supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Methods for microelectrode-guided posteroventral pallidotomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Selective D2 receptor stimulation induces dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Levodopa-induced dyskinesia: review, observations, and speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

A post-mortem study on striatal dopamine receptors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Are neostriatal dopamine receptors co-localized?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2896%2900157-X

7 January 2021

10.1016/S0169-328X(96)00157-X

Identifiers

DOI

1 reference

2 November 2017

1 reference

PubMed ID

8915594